Conglobatin |
Catalog No.GC18832 |
Conglobatin is a dimeric macrolide dilactone originally isolated from S.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 72263-05-9
Sample solution is provided at 25 µL, 10mM.
Conglobatin is a dimeric macrolide dilactone originally isolated from S. conglobatus. It disrupts binding of heat shock protein 90 (Hsp90) to the co-chaperone Cdc37 complex and induces downregulation of client protein expression in SK-BR-3 breast cancer cells. It also inhibits cell proliferation in HER2+ breast cancer cell lines (IC50s = 12.9-61.5 uM, respectively) and decreases the number of invasive cells in vitro. When combined with lapatinib , tumor growth of SK-BR-3 mouse xenografts was reduced to a greater degree than with conglobatin alone. Conglobatin has various anticancer effects in esophageal squamous cell carcinoma (ESCC) models as well, including an inhibition of cell proliferation in KYSE510 cells (IC50 = 9.31 uM). It also inhibits β1 integrin activation leading to a loss of cellular adhesion.
Review for Conglobatin
Average Rating: 5
(Based on Reviews and 36 reference(s) in Google Scholar.)Review for Conglobatin
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *